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Abstract
The molecular mechanisms regulating the expansion of the hematopoietic system including hematopoietic stem cells
(HSCs) in the fetal liver during embryonic development are largely unknown. The LIM-homeobox gene Lhx2 is a candidate
regulator of fetal hematopoiesis since it is expressed in the fetal liver and Lhx2
2/2 mice die in utero due to severe anemia.
Moreover, expression of Lhx2 in embryonic stem (ES) cell-derived embryoid bodies (EBs) can lead to the generation of HSC-
like cell lines. To further define the role of this transcription factor in hematopoietic regulation, we generated ES cell lines
that enabled tet-inducible expression of Lhx2. Using this approach we observed that Lhx2 expression synergises with
specific signalling pathways, resulting in increased frequency of colony forming cells in developing EB cells. The increase in
growth factor-responsive progenitor cells directly correlates to the efficiency in generating HSC-like cell lines, suggesting
that Lhx2 expression induce self-renewal of a distinct multipotential hematopoietic progenitor cell in EBs. Signalling via the
c-kit tyrosine kinase receptor and the gp130 signal transducer by IL-6 is necessary and sufficient for the Lhx2 induced self-
renewal. While inducing self-renewal of multipotential progenitor cells, expression of Lhx2 inhibited proliferation of
primitive erythroid precursor cells and interfered with early ES cell commitment, indicating striking lineage specificity of this
effect.
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Introduction
The mammalian hematopoietic system continuously generate
large numbers of functional erythroid, myeloid and lymphoid cells
throughout life. These functional cells originate from a small
number of hematopoietic stem cells (HSCs) that are maintained by
a process referred to as self-renewal [1–3]. The molecular basis for
the differentiation and self-renewal processes is largely unknown.
However, the hematopoietic system including the HSCs under-
goes a rapid and strictly controlled expansion during embryonic
development [4–7], suggesting that molecular and cellular analyses
of the embryonic hematopoietic system would offer insights into
these processes.
The first signs of embryonic hematopoiesis is the formation of
the blood islands on the yolk sac at embryonic day 7.5 (E7.5)
which almost exclusively contain primitive erythroid (EryP) cells
[8,9]. EryP cells are nucleated producing the embryonic form of
hemoglobin and this stage of embryonic hematopoiesis is referred
to as primitive hematopoiesis. The close association between
hematopoietic cells and vascular endothelium in the blood islands
led Sabin almost a century ago to postulate a common progenitor
cell for these cell types referred to as the hemangioblast [10], and a
progenitor cell with hemangioblast properties has recently been
identified [11,12]. Intraembryonic hematopoiesis is established
approximately at E10.5, initially in the so-called aorta-gonad-
mesonephros (AGM) region and shortly thereafter the fetal liver
becomes colonised by progenitor cells [7,13–19], marking the
switch from primitive to definitive hematopoiesis as the formation
of the whole spectrum of hematopoietic lineages including the
definitive erythroid (EryD) lineage commences at this stage. The
latter cell type differs from the EryP lineage in that they are
smaller, lack nucleus and produce adult hemoglobin [8,9].
Functional analyses of growth factor receptor-ligand interac-
tions have been informative in the understanding of cellular
interactions and signalling molecules important for both early
hematopoietic development and regulation of stem and progenitor
cells. The receptor tyrosine kinase c-kit and its ligand Stem Cell
Factor (SCF, also c-kit ligand, Steel factor or mast cell growth
factor) are essential for hematopoietic development since mice
lacking functional c-kit (White Spotting or W mutants) or SCF (Steel
or Sl mutants) die of a severe anemia in utero [14,20]. The SCF/c-
kit interaction plays a critical role in the expansion of definitive
hematopoietic cells in the fetal liver [21,22], and the SCF/c-kit
signalling pathway appears to be important for both self-renewal
of HSCs in vivo [23–26], and differentiation of HSCs and
progenitor cells in vitro and in vivo [14,25,27–30]. Another signal
transduction pathway important for the development of the
hematopoietic system is mediated by the glycoprotein 130 (gp130),
the common receptor and signal transducer for the interleukin-6
(IL-6) family of cytokines. [31,32]. Although the precise role of
gp130 in hematopoietic stem/progenitor cells is not fully
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fetal definitive hematopoiesis [33,34], and appears to influence
their function both in vivo and in vitro [35–38]. Thus, signalling
from the c-kit receptor and the gp130 signal transducer play an
import role in the development of the hematopoietic system as well
as for stem and progenitor cell function, but molecular
mechanisms modulating the activities of, and the interplay
between these receptors in stem cells remains to be elucidated.
Analyses of early mouse development is hampered by the
inaccessibility of the early embryo and the limited amount of
tissues at these stages. These aspects can be circumvented by using
the embryonic stem (ES) cell system since ES cells can be
differentiated in vitro into cystic structures called embryoid bodies
(EBs), and this process mimic the essential features of the
gastrulation process [39]. Similar to the embryo, the first
hematopoietic precursor cell population to develop in EBs is a
transient wave of the EryP lineage followed by the development of
progenitor cells of the various definitive hematopoietic lineages
(EryD and myeloid) [40]. Moreover, a progenitor cell population
showing hemangioblast characteristics that appears prior to the
development of primitive and definitive hematopoietic progenitor
cell populations, has been identified in the ES system as well as in
the embryo [11,12]. Thus, the ES/EB system represents a reliable
and reproducible model system for analysing the development and
regulation of the early embryonic hematopoietic system.
We have previously shown that expression of the LIM-
homeobox gene Lhx2 (MGI:96785, NM_010710) in hematopoietic
progenitor cells derived from ES cells differentiated in vitro can
promote self-renewal of a rare SCF-responsive progenitor cells
present in EBs [41]. These progenitor cells could be identified in
clonal assays and used to establish SCF-dependent multipotential
definitive hematopoietic progenitor cell (HPC) lines sharing many
basic properties with normal early fetal HSCs [41–43]. However,
these experiments were carried out by retroviral delivery of the
Lhx2 cDNA to the cells and a putative contribution to the
observed phenotype by inactivation of tumour suppressor genes or
activation of oncogenes caused by retroviral integration has not
been excluded. Moreover, expression from retroviral vectors in ES
cells differentiated in vitro is very inefficient [41,44], and therefore it
is not possible by using the retroviral system to systematically
analyse the effects of Lhx2 expression in the ES/EB system. Thus,
expression of Lhx2 can generate HSC-like cell lines but the
specificity and efficiency of this event is not known.
To further address the role of Lhx2 in during embryonic
development of the hematopoietic system, we have introduced
Lhx2 cDNA into Ainv15 ES cells where its expression is efficiently
regulated by a Tet-on system (Fig. 1A) [45]. Lhx2 expression
directly induce self-renewal of a distinct multipotent progenitor
cell within EBs in synergy with specific signalling pathways.
However, Lhx2 appears to have different and even opposite effects
in other cell types as its expression completely blocks proliferation
of EryP precursor cells and to some extent also EryD precursor
cells, and interferes with the initial steps of ES cell differentiation.
Results
Generation of ES cell lines with inducible Lhx2 expression
A systematic analysis of Lhx2 function in ES cells differentiated
in vitro using retroviral vectors is not possible due to the inefficient
and unpredictable expression pattern from such vectors in the ES/
EB system [41]. Introduction of Lhx2 cDNA into the Ainv15 ES
cells would allow for a more thorough analyses of Lhx2 function
since it is possible to conditionally regulate Lhx2 expression in ES
cells and during ES cell differentiation in vitro. Three different ES
cell line were generated and referred to as iLhx2, iLhx2-GFP and
iGFP ES cell lines (Fig. 1A). Efficient upregulation of mRNA and
protein expression from the different cDNA constructs introduced
into the respective ES cell line was achieved by adding doxycyclin
(dox) to the culture media (Fig. 1B, C). Maximum Lhx2 expression
was obtained within 24 hrs after dox addition and significant Lhx2
expression could be detected already 6 hrs after dox addition
(Fig. 1D). Addition of dox to control ES cells (and hence GFP
expression) did not interfere with any stage of ES cell
differentiation in vitro, neither on hematopoietic commitment
during EB formation nor on EryP precursor cells and definitive
CFCs in clonal assays of EB cells (Fig. 1E and F). Thus, this ES cell
system is amendable for systematic analysis of the specific effect(s)
of Lhx2 expression at different time points during differentiation in
vitro.
Lhx2 expression in clonal assays of EB cells inhibit
proliferation of EryP precursors and increase the
frequency of definitive CFCs
Since significant expression of Lhx2 occurred almost immedi-
ately after dox addition (within 6 hrs, Fig. 1D), we initially wanted
to analyse the effect of Lhx2 expression directly on various
hematopoietic progenitor cell populations by adding dox to the
clonal assays performed on day 6 EB cells. The most obvious
effects of turning Lhx2 expression on in clonal assays of EB cells
generated from the iLhx2 ES cell lines, were a complete block in
proliferation of EryP precursor cells and an approximate 3-fold
increase in the frequency of definitive CFCs (Fig. 2A, B). Adding
dox to EB cells generated from the iLhx2-GFP ES cell line only
partially blocked proliferation of EryP precursor cells and did not
significantly increase the frequency of definitive CFCs (Fig. 2A, B).
Gene expression analysis showed that the iLhx2-GFP ES cells
expressed approximately 50% less Lhx2 compared to the iLhx2
ES cells in the presence of saturating concentration of dox
(Fig. 2C). To confirm that the difference in phenotype between
iLhx2 and iLhx2-GFP ES cells was solely due to different levels of
Lhx2 expression, we replated EB cells generated from the iLhx2
ES cells in clonal assays with different concentrations of dox. The
level of Lhx2 expression increased with increasing concentrations
of dox (Fig. 2D), and increased expression of Lhx2 expression
correlated to the level of inhibition of proliferation of EryP
precursor cells (Fig. 2E), and to the synergistic effect on the
frequency of definitive CFCs (Fig. 2F). These results show that
Lhx2 have different effects on hematopoietic precursors within
EBs depending on what cells it is expressed in, and the level of
expression is important for these effects.
SCF and IL-6 is necessary and sufficient for the synergistic
effect on colony formation induced by Lhx2 expression
in clonal assays
We have previously shown that SCF is essential for the
generation and maintenance of HSC-like cell lines when Lhx2 is
expressed in hematopoietic cells [41,43,46]. We therefore wanted
to elucidate whether the synergistic effect was growth factor-
specific. The synergistic effect of Lhx2 expression on colony
formation was observed in most factor combinations containing
SCF whereas the effect was less pronounced or absent if SCF was
not included in the factor combination (Fig. 3A, B). No synergistic
effect of Lhx2 expression on colony formation was observed in
clonal assays when EB cells were replated in SCF and epo (Fig. 3A),
suggesting that activation of c-kit signalling is necessary but not
sufficient for the synergistic effect of Lhx2 expression on colony
formation. The least complex factor combination that consistently
Lhx2-Induced Self-Renewal
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Lhx2 expression was turned on was SCF/IL-6 (Fig. 3C). Thus,
simultaneous activation of c-kit and the gp130 signal transducer is
necessary and sufficient for the synergistic effect on colony
formation exerted by Lhx2 expression. The definitive progenitor
cells normally responding to SCF/IL-6/epo generate macrophage
colonies and definitive erythroid colonies usually containing
megakaryocytes and/or macrophages. Mature definitive erythro-
cytes assessed as hemoglobinised (red) cells rarely formed in the
colonies generated in the presence of dox (data not shown),
suggesting that Lhx2 expression also inhibited proliferation of the
EryD precursors as was also observed for the EryP precursors cells
(Fig. 2A), whereas it appears not to interfere with differentiation
into mast cells, megakaryocytes, macrophages and neutrophilic
granulocytes [41]. Proliferation of hematopoietic progenitor cells
expressing Lhx2 in clonal assays is completely dependent on
addition of growth factors since Lhx2 expression by itself did not
promote proliferation (Fig. 3A, No factors). Thus, Lhx2 expression
synergistically increase the frequency of CFCs in EBs and the
combination of SCF/IL-6 is necessary and sufficient for this Lhx2-
induced effect.
The increase in CFCs induced by Lhx2 expression directly
correlates to the efficiency in generating HSC-like cell
lines
We have previously shown that Lhx2 expression in hematopoi-
etic progenitor cells derived from ES cells differentiated in vitro and
from adult bone marrow could lead to the generation of HSC-like
cell lines [41–43,46]. However, since we used retroviral vectors in
these experiments we have not been able to exclude the
contribution of secondary genetic effects caused by the fortuitous
insertion of the retroviral vector into the genome leading to
inactivation of tumour suppressor genes or activation of onco-
genes. By using the Ainv15 ES cell lines containing the different
Figure 1. Generation of ES cell lines with inducible gene expression. A. The iLhx2, iLhx2-GFP and iGFP ES cell lines were generated by co-
transfecting Ainv15 ES cells with the plox vector containing the respective gene construct together with a vector containing the Cre recombinase as
described in ref. 45. The plox vector will be inserted into the loxp site down stream of the tet-responsive element (TRE) adjacent to the Hypoxanthine-
phosphoribosyltransferase (HPRT) gene. The reverse tet transactivator (rTA) is inserted into the ubiquitously expressed ROSA26 locus in the Ainv15 ES
cells. B. Lhx2 expression is measured by real-time PCR analysis of iLhx2 ES cells cultured in the absence (2Dox) or presence (+Dox) of dox for 2 days.
C. FACS analysis of the iLhx2-GFP ES cells cultured in the absence (-Dox) or presence (+Dox) of dox for two days. D. Lhx2 expression measured by RT-
PCR at different time points (in hrs) after dox addition to iLhx2 ES cells. Expression of HPRT was used as an internal control. E. Analysis of EryP
precursor cells in day 6 EB when dox is added to the control iGFP ES cells at different stages during in vitro differentiation. F. Analysis of definitive
CFCs in day 6 EBs when dox is added to iGFP cells at different stages of ES cell differentiation. – control, no addition of dox, +2 addition of dox during
ES cell differentiation from day 0 to day 6, 2+ addition of dox to the clonal assays of the EB cells, ++ addition of dox to both the ES cell differentiation
from day 0 to day 6 and to the clonal assays of the EB cells.
doi:10.1371/journal.pone.0002025.g001
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and sufficient for generating HSC-like cell lines and the efficiency
of this event. To address these issues we analysed the efficiency of
establishing HSC-like cell lines from individual colonies randomly
picked from the clonal assays of EBs generated from the iLhx2 and
iLhx2-GFP ES cell lines (e.g. addition of dox leads to high and
intermediate levels of Lhx2 expression, respectively). The
generated HSC-like cell lines were denoted dox-dependent
hematopoietic progenitor cell (DoxHPC) lines (see Materials and
Methods and ref. [47]). The most efficient way of generating
DoxHPC lines (60–69% of the picked colonies) was to transfer
colonies from the clonal assays containing SCF/IL-6/epo/dox to
liquid cultures containing SCF/IL-6/dox, performed on EBs
generated from the ES cells expressing the highest level of Lhx2
(iLhx2), (Table 1). A low frequency (3% of picked colonies) of
DoxHPC lines was obtained when the same approach was applied
to the EBs generated from the ES cell line expressing intermediate
levels of Lhx2 (iLhx2-GFP) (Table 1). No DoxHPC lines could be
generated when colonies from clonal assays containing SCF/epo/
dox of EBs generated from either iLhx2 or iLhx2-GFP ES cell line,
were transferred to liquid cultures supplemented with SCF/dox
(Table 1). The relative increase in CFCs when dox is added to the
clonal assays containing SCF/IL-6/epo performed on the EB cells
generated from the iLhx2 ES cells is on average 3,1-fold 60,5 (9
independent experiments) as compared to when dox is not added
to the clonal assays (Fig. 4A). With a 3,1-fold increase in colony
formation, the increase corresponds to 68% of the total number of
colony forming cells. This figure is similar to the efficiency in
generating DoxHPC lines from individual colonies (60–69%) in
equivalent experiments (Table 1), whereas the efficiency in
generating DoxHPC lines from individual colonies was low or
non-existing where limited or no synergistic effect was observed
after dox addition to the clonal assays (compare Figure 4A to
Table 1). Thus, the efficiency in generating DoxHPC lines directly
correlated to the increase in CFCs in EBs. The frequency of CFCs
in day 6 EBs when dox was added to the clonal assay was on
average 8,0610
2461,3610
24, hence the frequency of the Lhx2-
responsive progenitor cells would be 5,44610
24 (e.g. 68% of the
total CFCs) or 1 in 1838 EB cells.
To analyse if the growth requirements of established DoxHPC
lines were stable during culture we cultured them under different
conditions. If DoxHPC lines were cultured in IL-6 alone viability
rapidly decrease within 24 hrs and no live cells can be recovered
after 48 hrs (Fig. 4B). If the DoxHPC lines are cultured in SCF
alone the viability slightly decrease but the cells recover after a few
days and eventually start to proliferate albeit at a 3–4 times slower
rate compared to cells cultured in SCF and IL-6 (Fig. 4B). The
recovery of the cells correlated to an upregulation of expression of
the endogenous IL-6 gene (Fig. 4C), suggesting that endogenous
IL-6 expression can partly compensate for withdrawal of
exogenously added IL-6. Moreover, all DoxHPC lines tested thus
far rapidly differentiated into various hematopoietic lineages
Figure 2. Lhx2 expression in clonal assays inhibits proliferation of EryP precursor cells and increase the frequency of definitive
CFCs. A. Frequency of EryP precursor cells in day 6 EB cells generated from the iLhx2 or iLhx2-GFP ES cell lines if clonal assays were performed in the
absence (2Dox) or presence (+Dox) of dox B. Relative frequency of definitive CFCs in day 6 EB cells generated from the iLhx2 or iLhx2-GFP ES cell
lines if the clonal assays were performed in the absence (2Dox) or presence (+Dox) of dox. C. Relative expression of Lhx2 analysed by real-time PCR
comparing iLhx2 and iLhx2-GFP ES cells cultured in the presence of dox for 2 days. D. Relative Lhx2 expression analysed by real-time PCR in iLhx2 ES
cells cultured for 2 days in the presence of dox at the indicated concentrations. Maximal Lhx2 expression is reproducibly achieved in the presence of
2 mg/ml of dox which is arbitrarily set as 1. E. Frequency of EryP precursor cells in clonal assays of day 6 EBs performed in the presence of dox at the
indicated concentrations. F. Frequency of definitive CFCs in clonal assays of day 6 EBs performed in the presence of dox at the indicated
concentrations. *p,0,01 compared to no dox addition (0 ng/ml). **p,0,02 compared to no dox addition.
doi:10.1371/journal.pone.0002025.g002
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and mast cells) upon dox withdrawal [47], suggesting that Lhx2
expression induced self-renewal of a distinct SCF/IL-6 responsive
multipotential progenitor cell population present in EBs and
maintenance of this progenitor cell as DoxHPC lines requires
continuous c-kit and gp130 signalling.
Analyses of the effects of Lhx2 expression at different
stages of ES cell differentiation
Since Lhx2 expression appeared to promote proliferation of a
specific multipotential definitive hematopoietic progenitor cell
population in the EB we wanted to analyse the development of this
progenitor cell during EB formation, and whether Lhx2 expression
also could affect pre-hematopoietic mesoderm and/or the
hemangioblast population present in the EBs approximately at
day 3–4 of differentiation [11]. To start to address these issues we
performed clonal assays in the presence or absence of dox on EBs
generated from the iLhx2 ES cell line from day 2,5 to day 8 of
differentiation. These experiments revealed that the synergistic
effect of Lhx2 expression on colony formation was limited to the
time points when significant numbers of definitive hematopoietic
progenitor cells were detected within EBs starting at day 5 of
differentiation (Fig. 5A). The most pronounced synergistic effect
on colony formation of Lhx2 expression was obtained at day 6 of
differentiation when the highest frequency of progenitor cells
normally responding this factor combination was present in EBs
(Fig. 5A). After this time point the frequency of this progenitor cell
rapidly declined to be undetectable at day 8 of differentiation
(Fig. 5A). To analyse the effect of Lhx2 expression on the
hemangioblast population that is present during early EB
development, we replated day 3.25 EB cells in clonal assays
supplemented with SCF and VEGF, a factor combination that
promotes proliferation of blast cell colony-forming cell (CFC-Blast)
leading to formation of the blast cell colony that contains cells with
hemangioblast characteristics [11]. Replating of day 3,25 EBs in
this factor combination in the absence or presence of dox showed
that Lhx2 expression did not have a synergistic effect, but might
instead have a slight negative effect of the CFC-blast population
(Figure 5B). To elucidate whether Lhx2 expression affects
committed EryP precursors and/or commitment to this lineage
from the hemangioblast we added dox to day 3 and 4 EBs, when
commitment to this lineage occur, and replated the day 6 EBs
without dox when commitment to this lineage has normally
occurred. These experiments showed that significant but reduced
numbers of EryP precursors are present in day 6 EBs compared to
control EBs (Fig. 5C). The reduced number of EryP precursors
might be due to residual Lhx2 expression in the clonal assay after
dox withdrawal since this precursor appear to be sensitive to Lhx2
expression and it takes at least 24 hrs to decrease expression by
Figure 3. The synergistic effect of Lhx2 expression on colony
formation is growth factor-specific. A. Frequency of definitive CFCs
inday6EBcellsgeneratedfromiLhx2EScellsrespondingtotheindicated
growth factors/growth factor combinations in clonal assays performed in
theabsence (2Dox) or presence(+Dox)of dox. B. Frequencyof definitive
hematopoietic progenitor cells in day 6 EB cells responding to the
indicated growth factor combinations in clonal assays in the absence
(2Dox)orpresence(+Dox)ofdox.FactormixisTpo,IL-3,IL-6,Flt3L,epo.C.
Number of definitive hematopoietic progenitor cells responding to the
indicatedgrowthfactor combinationsin theabsence (2Dox)or presence
(+Dox) of dox. * p,0,002, ** p,0,01, *** p,0,005.
doi:10.1371/journal.pone.0002025.g003
Table 1. Efficiency in generating DoxHPC lines from
individual colonies in clonal assays of EB cells
ES cell
line
SCF/IL-6/epo
(Dox added to
clonal assays)
SCF/epo (Dox
added to clonal
assays)
SCF/IL-6/epo (Dox
added to EBs at day 4
and to clonal assay)
iLhx2 69% (66/96)* 0% (0/30) 65% (13/20)
60% (12/20)
iLhx2-GFP 3% (1/30) 0% (0/30) ND
*(Number of DoxHPC lines generated/Number of colonies picked)
ND, Not done.
doi:10.1371/journal.pone.0002025.t001
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withdrew it at day 5 to allow the expression level to decrease
significantly before the clonal assay was performed at day 6. In this
experiment the frequency of EryP precursor cells in day 6 EBs was
almost equal to that of control EBs (Fig. 5C), suggesting that Lhx2
expression blocks proliferation of precursor cells committed to the
EryP lineage but does not interfere with the commitment of such
precursors from the hemangioblast. These results suggested that
Lhx2 expression directly affects the emerging definitive multipo-
tential hematopoietic progenitor cell population whereas it has a
Figure 4. The efficiency in generating DoxHPC lines directly correlates to the synergistic effect of Lhx2 expression on colony
formation, and the generation and maintenance of the DoxHPC lines is optimal in SCF/IL-6. A. Summary of the synergistic effect of Lhx2
expression (+Dox) on definitive hematopoietic colony formation of EB cells generated from the iLhx2 ES cells (high level of Lhx2 expression in 2 mg/
ml of dox) or iLhx2-GFP ES cells (intermediate level of Lhx2 expression in 2 mg/ml of dox) replated in SCF/IL-6, or EB cells generated from the iLhx2 ES
cells replated in SCF alone. * p,0,0001. B. Relative growth of a DoxHPC lines cultured in either IL-6, SCF/IL-6, or SCF. C. Relative expression of IL-6
analysed by real-time PCR comparing a DoxHPC line cultured either in SCF/IL-6 or in SCF for 8 days.
doi:10.1371/journal.pone.0002025.g004
Figure 5. Analyses of the effect of Lhx2 expression at different stages of ES cell differentiation. A. Frequency of definitive CFCs in EB
cells generated from the iLhx2 ES cells at the indicated days of differentiation starting at day 2,5 analysed in clonal assays in the absence (2Dox) or
presence (+Dox) of dox. B. Frequency of CFC-Blast in day 3,25 EBs analysed in clonal assays with SCF and VEGF in the absence (2Dox) or presence
(+Dox) of dox. C. Frequency of EryP precursor cells in day 6 EBs if dox is added during the indicated time points of ES cell differentiation and omitted
in the clonal assays, compared to when no dox is added (Control) or if dox is added to clonal assays of control EBs (Control +Dox). The latter two
control experiments are equivalent to the experiments shown in Figure 2A using the iLhx2 ES cells. D. Relative number EB cells recovered at day 6 of
differentiation if dox is added to the iLhx2 ES cell line at the indicated time points during differentiation compared to when EBs are generated in the
absence of dox (Control) which is arbitrarily set as 1. * p,0,005 compared to control. ** p,0,01 compared to control. E. Frequency of formation of
secondary EBs in clonal assays of day 6 EBs if dox is added at the indicated time points during differentiation. Control EBs are generated without dox.
F. Frequency of definitive CFCs in day 6 EBs when dox is added at indicated days of differentiation. Control EBs are generated without dox. G.
Relative expression of the Brachyury gene during differentiation of the iLhx2 ES cell line revealing the progression of the gastrulation process in this
particular ES cell line during differentiated in vitro.
doi:10.1371/journal.pone.0002025.g005
Lhx2-Induced Self-Renewal
PLoS ONE | www.plosone.org 6 April 2008 | Volume 3 | Issue 4 | e2025limited effect on pre-hematopoietic mesoderm, limited and
perhaps even a slight negative effect on the hemangioblast
population.
To further study the effect of Lhx2 expression in ES cells and
during ES cell differentiation and gastrulation in vitro we added dox
to iLhx2 ES cells at different time points during differentiation and
analysed day 6 EBs. Expression of Lhx2 in ES cells cultured in ES
cell medium did not significantly affect their ability to self-renew,
based on growth rate and viability (data not shown). Expression of
Lhx2 during early ES cell commitment, e.g. from 2 days prior to
initiation of differentiation (Day -2) and on day 0 and 1 of
differentiation until day 6, suppressed EB formation whereas
initiation Lhx2 expression after day 2 did not significantly affect
the generation of EB cells (Fig. 5D). Moreover, expression of Lhx2
from day 0 and 1 lead to the formation of numerous secondary
EBs when day 6 EBs were replated in clonal assays (Fig. 5E),
suggesting that suppression of EB formation was most likely due to
that Lhx2 expression interfered with the initial commitment step
in the differentiation of ES cells. Lhx2 expression from day 0 and 1
also interfered with hematopoietic commitment as almost no
hematopoietic progenitor cells were detected in day 6 EB (Fig. 5F),
and expression from day 2 slightly affects hematopoietic
commitment whereas expression from day 3 instead increase the
frequency of definitive hematopoietic progenitor cells in day 6 EBs
(Fig. 5F). Expression of the gene Brachyury has been shown to be a
marker for formation of nascent mesoderm during primitive streak
formation and hence a marker for initiation and progression of the
gastrulation process in normal embryos as well as during ES cell
differentiation in vitro [40,48]. Brachyury expression during
differentiation of the Ainv15 ES cells is initiated between day 2
and 3 of differentiation and reaches maximum levels at day 4 of
differentiation to rapidly decline thereafter to be undetectable at
day 6 of differentiation (Fig 5G). These data further support that
Lhx2 expression mainly interferes with the initial step in ES cell
differentiation leading to the reduction of EB cells as well as
hematopoietic mesoderm, whereas it does not interfere with the
gastrulation process per se.
Lhx2 expression in intact EBs transiently induce
expansion of definitive hematopoietic progenitor cells
without exogenously added growth factors
The Lhx2-induced self-renewal of hematopoietic progenitor
cells in clonal assays of EB cells was strictly dependent on specific
and exogenously added growth factors (Fig. 3). The increase in
CFCs in day 6 EBs when Lhx2 was turned on at day 3 compared
to control EBs (Fig. 5F), suggested that Lhx2 expression in intact
EBs support self-renewal of hematopoietic progenitor cells
independently of exogenously added growth factors. To address
this issue and to elucidate if Lhx2 expression in intact EBs would
increase the efficiency in generating DoxHPC lines, we added dox
at day 3 and 4 of differentiation and analysed day 6 EBs for
progenitor cell content and gene expression pattern. Gene
expression analysis of day 6 EBs generated from the iLhx2 ES
cells when Lhx2 expression was turned on at day 4 showed that
genes primarily expressed by definitive hematopoietic cell
populations such as GATA-2 and b-globin (Beta major) and early
neuronal ectoderm (Pax6 and Otx2) were significantly upregulated
compared to control EBs, whereas genes expressed by EryP cells
(bH1 or Beta H1), cardiac mesoderm (Nkx2.5, Nfatc1, Tbx1),
vascular endothelium (VE-cadherin, Pecam, Flk-1), endodermal cell
populations (Sox17, Foxa2, GATA4), or various stem cell popula-
tions (Oct4, Rex1, Nanog, Nestin) were not changed (Fig. 6A). Other
early hematopoietic and/or endothelial-associated genes that
Lhx2 expression did not alter were CD41, CD34 and CD44.
Moreover, we did not detect any increased expression of the
mediators of the c-kit and gp130 signalling pathways when Lhx2
expression was turned on in day 4 EBs (e.g. SCF, c-kit, IL-6, gp130)
(Fig. 6A). The increased expression of genes associated with
definitive hematopoiesis was confirmed by that the progenitor cells
responding to SCF/IL6/epo had increased 5-8-fold within the
intact EB when Lhx2 was expressed during this time period
compared to control EBs (Fig. 6B). Furthermore, the synergistic
effect on colony formation of Lhx2 expression was also observed in
the clonal assays of the day 6 EBs when Lhx2 expression was
induced from day 3 or 4 (Fig. 6B), indicating both self-renewal and
differentiation of the distinct progenitor cell expanded by Lhx2
expression in EBs. Lhx2 expression between day 3 and 5 of
differentiation lead to an equivalent expansion of progenitor cells
in the EB suggesting that most of the expansion occurs between
days 3-5 of differentiation (Fig. 6B). Although expression of Lhx2
in intact EBs from day 4 of differentiation increase the frequency
of hematopoietic progenitors in day 6 EBs, it does not to increase
the efficiency in generating DoxHPC lines from the clonal assays
of day 6 EBs (65% of the picked colonies compared to 69% and
60% when dox was added only to the clonal assays, Table 1).
Thus, Lhx2 expression in intact EBs leads to both self-renewal and
differentiation of this distinct progenitor cell population.
During normal EB development in the absence of exogenously
added growth factors the frequency of hematopoietic progenitor
cells rapidly decline after day 6 of differentiation (Fig. 5A). To
elucidate if Lhx2 expression in intact EBs promote expansion of
hematopoietic progenitor cells to later stages when they are
normally exhausted, we also analysed progenitor cell content in
day 7 and 8 EBs when Lhx2 expression was turned on at day 4.
This experiment revealed that Lhx2 expression maintained
significant numbers of progenitor cells until day 8 EBs when they
are exhausted in the control EBs (Fig. 6C). The synergistic effect of
Lhx2 expression in the clonal assays of day 7 and 8 EBs was not
significant as in the clonal assays of day 6 EBs, further supporting
the notion that Lhx2 expression can only induced self-renewal of
this distinct hematopoietic progenitor cell for a limited time in
intact EBs. Thus, Lhx2 expression in intact EBs induce self-
renewal the specific hematopoietic progenitor cell independently
of exogenously added growth factors for a limited time (day 3–5)
during EB development.
Discussion
By using an efficient system to express Lhx2 during ES cell
differentiation in vitro we have shown that Lhx2 expression cause
three different phenotypes summarised in Figure 7: 1) self-renewal
of a distinct definitive multipotential hematopoietic progenitor cell
in EBs in a growth factor-specific manner, 2) complete block in
proliferation and differentiation of committed EryP precursor cells
and to some extent also EryD precursor cells, and 3) interference
with the initial steps in ES cell differentiation in vitro. The effect of
Lhx2 on hematopoietic progenitor cells is most likely due to a
direct effect on the emerging definitive multipotential progenitor
cells in the EBs and not due to an indirect effect by increasing
hematopoietic commitment from pre-hematopoietic mesoderm, or
by promoting proliferation of the hemangioblast cell population.
The lack of effect of Lhx2 expression in clonal assays of day 3 and
4 EBs when the hemangioblast is the dominating progenitor cell
population with hematopoietic potential, whereas expression in
intact EBs from day 3 and 4 to day 6 of differentiation expand
definitive hematopoietic progenitor cells, would suggest that Lhx2
expression does not induce self-renewal until the hemangioblast
cell has matured into a progenitor cell harbouring only definitive
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we have generated from ES cells previously have shown any
primitive hematopoietic potential [41,47], further supporting this
assumption. The frequency of the Lhx2-responsive progenitor cell
within day 6 EBs in our previous work using retroviral vectors was
usually less than 1 in 10
4 EB cells [41], whereas in this study we
can show that the frequency of the Lhx2-responsive progenitor cell
is 1 in 1838 EB cells. This frequency corresponds to 1-2 cells per
EB since each EB contain on average 2–3610
3 cells after 6 days of
differentiation [40], whereas in our previous work the frequency
corresponds to less than 1 progenitor per 3–4 EBs. This efficient
and growth factor-specific induction of self-renewal of a specific
multipotential progenitor cell present in EBs is unique to Lhx2 as
compared to other genes tested in the ES system, such as Hox11,
Hoxb4, Cdx4, Smad1, Stat5, mMixl1, and the BCR/ABL oncogene
[45,49–57].
Signalling via the c-kit receptor and the gp130 signal transducer
by IL-6 appear to be necessary and sufficient to promote Lhx2-
induced self-renewal of multipotential hematopoietic progenitor
cells in the ES/EB system. The growth factors that signal via
gp130, IL-6, IL-11, LIF (leukemia inhibitory factor), CNTF
(ciliary neurotrophic factor), OSM (oncostatin M), CT-1 (cardio-
trophin-1), CLC (cardiotrophin-like cytokine) and IL-27, affect a
plethora of different cell types [31,32], and it has been shown that
direct activation of gp130 does not require the specific ligand for
cell type-specific signalling [58]. Interestingly, signalling via c-kit
and direct activation of gp130 is also a potent regulator of human
hematopoietic progenitor/stem cells further supporting the idea
that modulation of these pathways profoundly influences stem cell
function also in cells of human origin [59–61]. Moreover, c-kit
receptor signalling together with gp130 signalling by IL-6 have
previously been shown to be involved in the maintenance of
immortalised HSC-like cell lines after transduction of HSCs with a
constitutively active Notch1 receptor, or a constitutively active b-
catenin that activates the canonical Wnt signalling pathway
[62,63], although the specificity or efficiency of these events are
Figure 6. Lhx2 expression in intact EBs transiently induce expansion of definitive hematopoietic progenitor cells in the absence of
exogenously added growth factors. A. Gene expression analysis by real-time PCR on day 6 EB generated from the iLhx2 ES cells comparing
control EBs (2Dox) to those where Lhx2 expression was turned on at day 4 of differentiation (+Dox). B. Frequency of definitive CFCs responding to
SCF/IL-6/epo in clonal assays of day 6 EBs in the presence (+Dox) or absence (2Dox) of dox, if dox was added at day 3 or 4 of differentiation, or if dox
was present between day 3 and 5 of differentiation. Control is day 6 EBs generated without dox. C. Frequency of definitive CFCs responding to SCF/
IL-6/epo in clonal assays of day 6, 7 and 8 EBs in the presence (2Dox) of absence (+Dox) of dox if dox was added or not at day 4 of differentiation.
Hence, the following combinations were analysed: 22 no dox added to the ES cells differentiation or to clonal assays of EB cells, 2+ dox was added
to clonal assays of day 6, 7 and 8 EB cells. +2 dox was added to day 4 EB and no dox was added to clonal assays of the day 6, 7 and 8 EB cells. ++ dox
was added to day 4 EBs and to the clonal assays of the day 6, 7 and 8 EB cells. Asterisks indicate where the difference in CFC between clonal assays
performed in the absence or presence of dox is statistically significant, *p,0,005, **p,0,05.
doi:10.1371/journal.pone.0002025.g006
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with gp130 signalling are potent regulators of hematopoietic stem/
progenitor cells including those of human origin, and we have
shown that Lhx2 expression efficiently modulate the interplay
between these receptors. To elucidate the function of Lhx2 in
stem/progenitor cells we have done global gene expression
analyses comparing the Lhx2
+ DoxHPC lines to their Lhx2
2
progeny upon dox withdrawal [47], and started to address the
contribution of different signalling pathways identified in this
screen. Based on the function of Lhx2 in stem/progenitor cell
populations in various organ systems such as olfactory epithelium,
forebrain ventricular zone, hair follicles, and the progress zone
during limb development [64–68], elucidation of Lhx2 function
would give insights into progenitor/stem cell physiology also in
non-hematopoietic organs.
The generation of HSC-like cell lines in our previous work was
a relatively rare event and we could not exclude the influence from
secondary genetic effects due to retroviral integration, which has
been shown to be a non-random event causing a proliferative
advantage of the transduced clone [69]. Our inability to generate
DoxHPC lines in SCF alone suggests that retroviral insertion
might contribute to the generation of HSC-like cell lines in SCF
alone in our previous work [41,46]. Upregulation of endogenous
IL-6 gene expression upon IL-6 withdrawal from DoxHPC lines
suggests that endogenous IL-6 expression could further contribute
to Lhx2 induced self-renewal in SCF alone. However, the results
obtained herein exclude the influence of retroviral insertion in the
generation of HSC-like cell lines and strongly suggest that
induction of self-renewal of the multipotential progenitor cell is a
direct and specific effect of Lhx2 expression together with c-kit and
gp130 signalling.
In contrast to the strict dependence on exogenously added
growth factors for Lhx2-induced self-renewal of cells in clonal
assays, Lhx2 expression in intact EBs transiently induce self-
renewal of these progenitor cells independent of exogenously
added growth factors. This observation suggests that the EB
environment can provide the growth factors required for Lhx2-
induced self-renewal. SCF is expressed during ES cell differenti-
ation in vitro [40,70,71], whereas IL-6 is not expressed during the
early stages of EB development [70], and we have not seen any
evidence for that Lhx2 expression in EBs upregulate IL-6
expression (Fig. 6A). We have previously shown that the HSC-
like cell lines expressing Lhx2 self-renew by a cell nonautonomous
mechanism which is in agreement with the cell nonautonomous
hematopoietic phenotype in Lhx2
2/2 mice [42,64]. Since Lhx2 is
normally expressed in a mesenchymal cell population (hepatic
stellate cells) in the fetal liver and these cells are important for the
differentiation, organization and expansion of all cell types in the
liver including those of the hematopoietic niche [64,72], it would
suggest that Lhx2 regulates genes in mesenchymal cells encoding
mediators involved in cell-to-cell interactions. Lhx2 expression in
mesenchymal cells in addition to expression in hematopoietic cells
might therefore enhance the effect on hematopoietic cells in intact
EBs and the transient nature of the expansion (day 3–5 of EB
development) suggests that such interactions are only possible
during early EB development. Elucidation of the molecular basis
for Lhx2-induced self-renewal might therefore give insights into
both cell autonomous and cell nonautonomous mechanisms
regulating normal HSCs function.
Another obvious effect of Lhx2 expression on hematopoietic
precursors was the complete block in proliferation of committed
EryP precursor cells and to some extent also of EryD precursor
cells. This observation could explain the large fluctuation in
erythropoiesis in vivo seen in stem cell-deficient mice engrafted with
adult HSC-like cell lines expressing Lhx2, whereas generation of
myeloid cells appeared to be relatively unaffected [46]. Since the
level of Lhx2 expression is critical for the inhibition of erythroid
development, these fluctuations could simply reflect fluctuations in
the level of Lhx2 expression in erythroid precursors, and hence
when Lhx2 expression is below a critical threshold the erythroid
precursor can escape the inhibition. We also noticed a significantly
decreased mean corpuscular hemoglobin concentration (MCHC)
in erythrocytes originating from the HSC-like cell lines in the
engrafted animals [73], suggesting that Lhx2 expression could
Figure 7. An overview of the effects of Lhx2 expression during ES cell differentiation in vitro. 1) Lhx2 expression and simultaneous
activation of the c-kit receptor tyrosine kinase and gp130 signal transducer via IL-6 directly induce self-renewal of a distinct multipotential definitive
hematopoietic progenitor cell (Def. HPC) present in the EB (1a) leading to the generation of HSC-like cell lines (DoxHPC lines) strictly dependent on
Lhx2 expression and SCF/IL-6 for continuous self-renewal in vitro (1b). 2) Lhx2 expression inhibits proliferation of committed primitive erythroid (EryP)
precursor cells (2a) and definitive erythroid (EryD) precursor cells (2b). 3) Lhx2 expression interferes with the initial step in ES cell differentiation
whereas it does not interfere with the gastrulation process. Mast, mast cells. Mac, macrophages. Neut, neutrophilic granulocyte. Meg,
megakaryocytes.
doi:10.1371/journal.pone.0002025.g007
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domain-containing transcription factor and transcriptional
regulators containing LIM-domains (Lmo2) and LIM-domain-
interacting domains (Ldb1) are known to be critically involved in
erythroid differentiation [74–76]. Since Lhx2 is not normally
expressed in hematopoietic cells, the LIM-domain of the Lhx2
protein might physically interfere with these protein interactions
and depending on the amount of Lhx2 protein in the cell cause
dominant negative effects leading to the block in erythroid
development and/or altered globin expression.
It has been suggested that expression of the Lhx2 gene is
repressed in ES cells by the Polycomb complex [77,78], implying
that Lhx2 would promote differentiation of ES cells. However, our
data reveal that Lhx2 expression does not have any obvious effects
on the self-renewal of ES cells but it does interfere with the early
steps in ES cell differentiation leading to reduced number of EB
cells and suppression of hematopoietic mesoderm. These effects
are only seen if Lhx2 is turned very early during ES cell
differentiation (primarily from day 0 and 1) whereas expression
after day 2 has subtle effects on the differentiation. Since our
differentiation protocol is prone towards mesodermal commitment
and is inefficient in promoting ectodermal and endodermal
commitment, our results can be interpreted in at least two
different ways. Firstly, Lhx2 interferes with conversion of primitive
ectoderm to more differentiated tissues. Secondly, Lhx2 expression
promotes differentiation towards a lineage that is not supported by
our differentiation protocol. One of the first cell types expressing
Lhx2 in the developing embryo is the neuronal ectoderm of the
prospective forebrain prior to E9 (unpublished observation) and
gene expression analysis of the day 6 EBs when Lhx2 was turned
on at day 4 revealed a significant upregulation of the forebrain
markers Pax6 and Otx2. These results suggest that Lhx2 might
promote neuronal differentiation which is not supported by our
differentiation protocol and neuronal commitment might be more
efficient if Lhx2 is turned very early during ES cell differentiation
and hence cause the reduced formation of EB cell and suppression
of mesodermal commitment. Which of these alternatives that are
correct are presently under investigation. Collectively these results
show that the effects of Lhx2 expression have striking lineage
specificity and that the level of expression is important for these
effects. This work provides the first attempt to understand the wide
array of functions that Lhx2 have in different organs during
embryonic development such as the hematopoietic system, the
liver, forebrain and neuronal retina.
Materials and Methods
Generation of ES cells with inducible gene expression
The Ainv15 ES cell line was maintained on irradiated mouse
embryonic feeder (MEF) cells in Dulbeccos modified Eagle
medium (DMEM) (Gibco-BRL, United Kingdom) supplemented
with 15% fetal calf serum (FCS) (Boehringer, Germany),
1.5610
24 M monothioglycerol (MTG) (Sigma, Germany) and
LIF (Chemicon, Ca, USA). Green fluorescent protein (GFP)
cDNA, Lhx2 cDNA or Lhx2 cDNA linked to a GFP cDNA
preceded by an internal ribosomal entry site (Lhx2-GFP), was
inserted into the plox vector and transfected into the Ainv15 ES
cells together with Cre recombinase cDNA as previously described
[45]. The plox vector will be inserted into the loxp site down
stream of the tet-responsive element (TRE) adjacent to the
Hypoxanthine-phosphoribosyltransferase (HPRT) gene by recombination
between the chromosomal and plasmid loxp sites (Fig. 1A).
Reconstitution of a functional Neo gene by the promoter-ATG
sequence (PGK-ATG) allows for selection of successful integration
events (Fig. 1A), and hence transfected ES cells were subsequently
cultured in 200 mg/ml G418 (Gibco-BRL). Clones of G418
R ES
cells transfected with the respective gene construct were isolated,
pooled and expanded. The resulting cell lines are referred to as
iGFP, iLhx2 and iLhx2-GFP ES cell lines, respectively. Induction
of gene expression was carried out by adding dox to a final
concentration of 2 mg/ml of dox if not stated otherwise. Induction
of Lhx2 expression was done using the iLhx2 ES cell line if not
stated otherwise.
Differentiation of ES cell in vitro
The iGFP, iLhx2 and iLhx2-GFP ES cell lines used for in vitro
differentiation were made feeder-independent in serum-free
medium as previously described [79,80]. Briefly, ES cells cultured
on MEF cells were treated with Acutase (Chemicon International,
Cat. No. SF006), transferred to gelatinized culture flasks in
ESGRO Complete Clonal grade medium (Chemicon Internation-
al, Cat. No. SF001) and passaged in this medium until no MEFs
were present and were subsequently maintained in this medium by
1:4 to 1:5 splits. For differentiation, ES cells were treated with
Acutase , washed and transferred at various densities (10
328610
3
cells/ml) into Iscoves modified Dulbeccos media (IMDM) (Gibco-
BRL) supplemented with 15% FCS (Integro Inc., The Nether-
lands), 4.5610
24 M MTG, 5% Protein Free Hybridoma Medium
II (PFHMII, GIBCO) and 25 mg/ml ascorbic acid (Sigma). EBs
were collected after different days of differentiation, resuspended
in Acutase and incubated for three minutes. Two ml of FCS was
added and the cells were gently passaged through a syringe with a
20-gauge needle. Ten ml of IMDM supplemented with MTG was
added; the cells were spun down and resuspended in fresh IMDM
medium supplemented with MTG and 5% FCS.
Clonal progenitor cell assays of EB cells
The clonal assays were carried out in IMDM containing 1%
methylcellulose (Fluka, Switzerland) and supplemented with L-
glutamine, 300 mg/ml iron-saturated transferrin (Boehringer), 5%
PFHMII, 10% plasma-derived serum (Antech Inc., Tx, USA),
with or without doxycyclin (dox) (Sigma) and with the indicated
growth factors. Growth factors used were: mouse SCF (R&D
Systems) at 100 ng/ml, human IL-6 (R&DSystems) at 10 ng/ml,
mouse thrombopoietin (tpo) (R&DSystems) at 20 ng/ml, mouse
Flt3L (R&DSystems) at 20 ng/ml, IL-3 at 1% of conditioned
media from a cell line transfected with mouse IL-3 cDNA [81] and
human erythropoietin (epo) (Eprex Janssen-Cilag, Sweden) at 4
IU/ml. EB cells were plated in triplicates in a final volume of
1.25 ml in 35-mm Petri dishes (Falcon 1008) at 7610
4 to 2610
5
cells/dish. The frequency of EryP precursor cells was determined
by scoring the number of EryP colonies after 5 days of incubation
and the frequency of definitive colony-forming cells (CFCs) was
determined by scoring the number of definitive hematopoietic
colonies after 9–10 days of incubation.
Generation and maintenance of DoxHPC lines
Clonal assays containing either SCF/IL-6/epo/dox or SCF/
epo/dox were performed on day 6 EBs generated from the iLhx2
and iLhx2-GFP ES cell lines. Individual colonies were randomly
picked from the clonal assays after 9–10 days of incubation,
transferred to 96-well plates and expanded in IMDM supple-
mented with 5% FCS, 1.5610
24 M MTG, and SCF/IL-6/dox or
SCF/dox. The individual colonies were cultured for at least 3
weeks after which the cells were analysed for cell morphology by
May-Gru ¨nwald Giemsa staining of cytospun cells, and at this stage
the cultures contained cells either with mast cell morphology or
blast cell-like morphology (ref. 47 and data not shown). All cultures
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generated stable cell lines and are referred to as dox-dependent
hematopoietic progenitor cell (DoxHPC) lines. The DoxHPC lines
were subsequently maintained in this media at cell densities
between 5610
5 and 2610
6 cells/ml as previously described for
other Lhx2-induced HSC-like cell lines (HPC and BM-HPC lines)
[42,46]. The cultures containing cells with mast cell morphology
remained as such despite maintained Lhx2 expression. The
DoxHPC lines down regulated Lhx2 expression by .95% within
24 hrs after dox withdrawal and all DoxHPC lines tested thus far
are multipotential as they differentiate into various myeloid cells
(megakaryocyte, macrophages, neutrophilic granulocytes, mast
cells) upon dox withdrawal [47]. No cell line could be established
from EBs generated from the control iGFP ES cell line in the
presence of dox, or from EBs generated from the iLhx2 ES cell
line in the absence of dox, as such cells differentiated into mast
cells under these culture conditions.
Gene expression analysis
Total RNA was extracted from cell pellets with RNeasy Plus
Mini Kit (Qiagen). cDNA was synthesized using the First-strand
cDNA synthesis Kit (Amersham Biosciences). Real-time PCR
reactions were carried out in triplicates using SYBR green PCR
master mix (Applied Biosystems Ca. US) and PCR products were
detected with an ABI prism 7000 instrument (Applied Biosystems).
The expression levels of the genes tested were normalized to the
expression levels of house keeping gene Gapdh (Glyceraldehyde-3-
phosphate dehydrogenase) and confirmed with one additional
house keeping gene Tbp (TATA box binding protein). The
following primers were used: Gapdh forward primer (F) CGTGT-
TCCTACCCCCAATGT and reverse primer (R) TGTCATCA-
TACTTGGCAGGTTTCT, Tbp F GAATTGTACCGCAGC-
TTCAAAA and R AGTGCAATGGTCTTTAGGTCAAGTT,
CD34 F CTTGGGCACCACTGGTTATTTC and R GGTCT-
TCACCCAGCCTTTCTC, CD41 F GCTCCGGCTCACAGC-
TACTG and R ATCATTGGCTGCTTCAATCTTCA, Gata2 F
GGCACGGGCCACTACCT and R TCGTCTGACAATTTG-
CACAACAG, bH1 F AGGCAGCTATCACAAGCATCTG
and R AACTTGTCAAAGAATCTCTGAGTCCAT, b major
F GTGAGCTCCACTGTGACAAGCT and R GGTGGCCC-
AGCACAATCACGATC, Flk1 F ACTGCAGTGATTGCCAT-
GTTCT and R TCATTGGCCCGCTTAACG, SCF F GAAAA-
CGCACCGAAGAATATAAAAG and R TCTAGTTTCTGG-
CCTCTTCGGA, c-kit F CACTCGCACGGGCACAT and R
AAGTTTGGCAGGATCTCTAACAAAC, CD44 F TCCGAA-
TTAGCTGGACACTCAA and R TCTCCTCATAGGACCA-
GAAGTTGTG, IL-6 F ACAAGTCGGAGGCTTAATTACA-
CAT and R AATCAGAATTGCCATTGCACAA, gp130 F
TGCTGGGCGTCTTGTTCTG and R ATATGACTCTTG-
GAAGGATCAGGAA, epoR F GGATGGACTTCAACTACA-
GCTTCTC and R CCTGGTGCAGGCTACATGACT, Otx2
F GAGCTCAGTCGCCACCTCTACT and R CCGCATTG-
GACGTTAGAAAAG, Pax6 F CCACCCATGCCCAGCTT and
R AACTGACACTCCAGGTGAAATGAG, Oct4 F TGAGC-
C>GTCTTTCCACCA and R TACCTCCCTTGCCTTGGC,
GATA4 F CACCCCAATCTCGTAGATATGTTTG and R
GGTAGTGTCCCGTCCCATCTC, VE-Cad F AGCGCAG-
CATCGGGTACT and R GTTATAGATGTTTCCCTGCTT-
GGTTAT, Pecam F CTGCAGGCATCGGCAAA and R GCA-
TTTCGCACACCTGGAT, Nkx2.5 F CCAAGTGCTCTCC-
TGCTTTCC and R GCCATCCGTCTCGGCTTT, Nfatc1 F
CCATACGAGCTTCGGATCGA and R AGTAACCGTGTA-
GCTGCACAATG, Tbx5 F CGTTTGGACACATTATCCT-
GAACT and R TGAACCGAACCCATTATTTTCG, Nestin F
CTCTTCCCCCTTGCCTAATACC and R TTTAGGATAG-
GGAGCCTCAGACAT, Foxa2 F GGCCAGCGAGTTAAAG-
TATGCT and R CTCGGGCTCCGCGTAGTAG, Sox17 F
CCCAACACTCCTCCCAAAGTATC and R TTCCCTGTCT-
TGGTTGATTTCTC, Rex1 F TCACTGTGCTGCCTCCA-
AGT and R GGGCACTGATCCGCAAAC, Nanog F AAACC-
AGTGGTTGAAGACTAGCAA and R TGCAATGGATGCT-
GGGATACT.
Reverse transcriptase (RT) PCR was performed using Taq
polymerase (Amplicon, Denmark) on cDNA prepared from
feeder-independent iLhx2 ES cells cultured without dox (0 hrs)
and in 2 mg/ml of dox for 6, 12, 18 and 24 hours. The samples
were loaded on the 1% Agarose gel and the PCR primers used
were Lhx2 F AAAAGACAAAGCGCATGCGGC and R CAGG-
CACAGAAGTTAAGACTG, Hprt F CACAGGACTAGAA-
CACCTGC and R GCTGGTGAAAAGGACCTCT.
GFP expression analysis was carried in a FACSCalibur
TM
(Becton Dickinson, Ca USA) using CellQuestPro measuring
fluorescence in the FL1 channel on the feeder-independent
iLhx2-GFP ES cells cultured as described previously in the
presence or absence of 2 mg/ml of dox for 2 days.
Statistical analysis
Data are presented as mean6standard deviation (SD). p values
were calculated using Student’s t test and p values ,0,05 were
considered as statistically significant.
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